22 Aug, EOD - Indian

Nifty 50 24870.1 (-0.85)

SENSEX 81306.85 (-0.85)

Nifty Bank 55149.4 (-1.09)

Nifty Next 50 67540.1 (-0.64)

Nifty Midcap 100 57629.75 (-0.14)

Nifty Pharma 22265 (0.39)

Nifty Smallcap 100 17919.5 (-0.26)

Nifty IT 35440.85 (-0.79)

22 Aug, EOD - Global

NIKKEI 225 42633.29 (0.05)

HANG SENG 25339.14 (0.93)

S&P 6496.75 (1.51)


Mid Session News

You are Here : Home > News > Mid Session News >

(13 Aug 2025, 12:34)

Sensex jumps 226 pts; pharma shares climb for 3rd day


The headline equity benchmarks traded with modest gains in early afternoon trade, tracking positive global cues. Upbeat domestic CPI data further boosted market sentiment. Investors are closely watching the ongoing earnings season, FII activity, and key macroeconomic data releases expected later this week.

The Nifty traded above the 24,600 level. Pharma shares extended gains for the third trading session.

At 12:30 IST, the barometer index, the S&P BSE Sensex advanced 226.02 points or 0.28% to 80,461.48. The Nifty 50 index added 108.40 points or 0.44% to 24,607.55.

In the broader market, the S&P BSE Mid-Cap index rose 0.51% and the S&P BSE Small-Cap index added 0.41%.

The market breadth was positive. On the BSE 2,068 shares rose and 1,800 shares fell. A total of 199 shares were unchanged.

Economy:

India’s retail inflation, measured by the Consumer Price Index (CPI), eased to 1.55% in July, down 55 basis points from 2.10% in June, according to data from the Ministry of Statistics & Programme Implementation. This marks the lowest year-on-year inflation rate since June 2017.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, shed 0.02% to 12.22. The Nifty 28 August 2025 futures were trading at 24,662.60 at a premium of 55.05 points as compared with the spot at 24,607.55.

The Nifty option chain for the 28 August 2025 expiry showed a maximum call OI of 68 lakh contracts at the 25,000 strike price. Maximum put OI of 42.7 lakh contracts was seen at 24,000 strike price.

Buzzing Index:

The Nifty Pharma index rose 1.34% to 22,045.35. The index added 3% in the three trading session.

Alkem Laboratories (up 4.44%), Abbott India (up 2.75%), Laurus Labs (up 2.25%), Granules India (up 1.85%) and Zydus Lifesciences (up 1.66%), Divis Laboratories (up 1.53%), Cipla (up 1.36%), Dr Reddys Laboratories (up 1.12%), Lupin (up 0.98%) and Natco Pharma (up 0.71%) added.

On the other hand, Ipca Laboratories (down 2.08%), Ajanta Pharma (down 1.34%) and Torrent Pharmaceuticals (down 0.54%) edged lower.

Stocks in Spotlight:

ACME Solar Holdings shed 0.93%. The company announced that its wholly owned subsidiary, ACME Hybrid Urja has secured Rs 3,184 crore in long-term financing from REC for a 280 MW Firm & Dispatchable Renewable Energy (FDRE) project contracted with NHPC.

Cochin Shipyard rose 0.47%. The company reported a 7.8% rise in consolidated net profit to Rs 187.83 crore on a 38.5% increase in revenue from operations to Rs 1,068.59 crore in Q1 FY26 over Q1 FY25.

FSN E-Commerce Ventures jumped 7.15% after the company reported 79% rise in net profit to Rs 24 crore on a 23% increase in revenue from operations to Rs 2,155 crore in Q1 FY26 as compared with Q1 FY25.

More News

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +